Product Image

Glucosamine 500 mg Chondroitin 400 mg

4.8
★ ★ ★ ★ ★
(2006 ratings)
Sodium 120 mg
Potassium 195 mg
Product Image
Score65
Substantial glucosamine and chondroitin amounts make this a credible joint formula, not a heart supplement. Potassium is modest and accompanied by sodium.
How scoring works
Capsule
Quantity:150 Capsule(s) • (50 servings)
Goals:

Score 65

Substantial glucosamine and chondroitin amounts make this a credible joint formula, not a heart supplement. Potassium is modest and accompanied by sodium.
How scoring works
$23.24($0.46 per serving)
iHerb
$ 30.99
iHerb
$ 30.99
Report prices

Analysis

The serving supplies 1,500 mg of glucosamine sulfate and 1,200 mg of chondroitin sulfate, giving the formula a clear joint-support purpose. Both main amounts are disclosed, which makes the core formula easy to assess.

Potassium reaches 195 mg, while sodium is 120 mg. That balance offers only a modest mineral contribution and does not turn the capsules into a focused electrolyte or cardiovascular product.

The formula suits someone who wants glucosamine and chondroitin and views the minerals as incidental. Chondroitin creates a relevant interaction concern for anticoagulant users, while added potassium may be unsuitable for some people with reduced kidney function or potassium-retaining medicines.

Who is it for
  • Adults seeking a glucosamine-chondroitin formula
  • People who prefer capsules over tablets
Best for
  • Joint-focused supplementation
  • Clearly disclosed core active amounts

Pros

  • Discloses both main joint ingredients
  • Uses glucosamine sulfate 2KCl
  • Moderate potassium contribution

Cons

  • Little direct heart-health relevance
  • Requires three capsules per serving
  • Potassium yield from the compound is not fully explained

Warnings

  • Chondroitin may increase bleeding risk with warfarin or other anticoagulants.
  • The 195 mg potassium serving may not suit people with impaired kidney function or medicines that retain potassium.

Nutrient quality

54 Moderate impact

The sodium source is not identified, so its form quality cannot be assessed confidently. The 120 mg sodium amount is too low for substantial sweat replacement.

.

Ingredient transparency

74 High impact

Active amounts are listed clearly. No proprietary blend hides a key dose, but other ingredients and full directions are missing.

.

Customer satisfaction

66 High impact

The supplied average rating is generally strong and the rating volume provides an aggregate signal. No comment-level evidence is provided to assess recurring complaints or confirm how experience matches the intended purpose.

.

Value for money

63 Moderate impact

The broader formula may offer utility, though sodium-specific value is only moderate. The main non-electrolyte actives are purposeful rather than obvious padding.

.
Report analysis

Ingredients

IngredientAmount per serving
Calories
10 Calorie(s)
Total Carbohydrates
2 Gram(s)
Sodium
120 mg
Potassium
195 mg
Glucosamine Sulfate (Glucosamine Sulfate 2KCl)
1500 mg
Chondroitin Sulfate
1200 mg
Adults 18–50
Report overview
Sodium · 120 mg OverallScore65
D Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyA+ Value

The label gives a sodium amount without naming its source, limiting purity assessment. 120 mg is below the target range for intense sweat replacement; supporting electrolytes are present, but their forms do not establish high bioavailability; no trace-mineral complex or buffering compound is disclosed. The disclosed carbohydrate or sugar load is low, and no artificial color is listed; the low serving cost provides strong value.

Potassium · 195 mg OverallScore57
D+ Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyC Value

The potassium amount is moderate and appears to come from the potassium chloride component of glucosamine sulfate. The label likely reports elemental potassium, but it does not clearly separate compound weight from elemental yield. Low serving cost supports reasonable value, although joint-support ingredients are the main purpose.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials.
    Poorolajal J; Zeraati F; Soltanian AR; Sheikh V; Hooshmand E; Maleki A · PloS one · 2017
    Meta-analysis1,213 participants23 studies pooledHeart Health forPotassium
  2. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies.
    D'Elia L; Cappuccio FP; Masulli M; La Fata E; Rendina D; Galletti F · Nutrients · 2023
    Meta-analysis332 participants5 studies pooledHeart Health forPotassium
  3. Potassium intake and risk of stroke in women with hypertension and nonhypertension in the Women's Health Initiative.
    Seth A; Mossavar-Rahmani Y; Kamensky V; Silver B; Lakshminarayan K; Prentice R; Van Horn L; Wassertheil-Smoller S · Stroke · 2015
    Cohort study90,137 participantsHeart Health forPotassium
  4. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies.
    D'Elia L; Barba G; Cappuccio FP; Strazzullo P · Journal of the American College of Cardiology · 2011
    Meta-analysis247,510 participants11 studies pooledHeart Health forPotassium
  5. Associations between sodium, potassium, and blood pressure: results from the Hispanic Community Health Study/Study of Latinos, a prospective cohort study.
    Swift SL; Sotres-Alvarez D; Raij L; Wassertheil-Smoller S; Schneiderman N; Llabre M; Zeki Al Hazzouri A; Rundek T; Van Horn L; Daviglus M; Castaneda S; Youngblood M; Mossavar-Rahmani Y; Elfassy T · The American journal of clinical nutrition · 2024
    Cohort study11,429 participantsHeart Health forPotassium
  6. Serum potassium levels provide prognostic information in symptomatic heart failure beyond traditional clinical variables.
    Toledo CC; Vellosa Schwartzmann P; Miguel Silva L; da Silva Ferreira G; Bianchini Cardoso F; Citelli Ribeiro V; Paim LR; Antunes-Correa LM; Carvalho Sposito A; Matos Souza JR; Modolo R; Nadruz W; Fernandes de Carvalho LS; Coelho-Filho OR · ESC heart failure · 2021
    Cohort study178 participantsHeart Health forPotassium
  7. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality.
    Núñez J; Bayés-Genís A; Zannad F; Rossignol P; Núñez E; Bodí V; Miñana G; Santas E; Chorro FJ; Mollar A; Carratalá A; Navarro J; Górriz JL; Lupón J; Husser O; Metra M; Sanchis J · Circulation · 2019
    Cohort study2,164 participantsHeart Health forPotassium
  8. Effect of high potassium diet on endothelial function.
    Blanch N; Clifton PM; Petersen KS; Willoughby SR; Keogh JB · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2015
    Randomized trial35 participantsHeart Health forPotassium